Exercise Dosing Trial for Individuals With Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Parkinsons Disease
Interventions
OTHER

High-intensity, aerobic exercise.

"Aerobic exercise will blend unsupervised moderate and supervised high intensity exercise. It will consist of walking/jogging modalities, dependent on the subject's level of bradykinesia, paced by the subject's level of perceived exertion. The exercise protocol will be designed to target an total of at least 150 minutes of cardio exercise per week.~Exercise training will be performed 5 times per week for 6 weeks, consisting of 3 supervised high intensity sessions and 2 at home moderate intensity sessions. High intensity sessions will be performed on a treadmill at an intensity rating of \~ 15 and 17 on a rating of perceived exertion (RPE) scale of 6 to 20. The moderate intensity exercise will target an RPE of \~10 - 12 and participants will be asked to complete this on their own."

Trial Locations (1)

22908

University of Virginia Health System, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT02676804 - Exercise Dosing Trial for Individuals With Parkinson's Disease | Biotech Hunter | Biotech Hunter